160 related articles for article (PubMed ID: 35453260)
21. Reevaluating Rifampicin Breakpoint Concentrations for Mycobacterium tuberculosis Isolates with Disputed
Wang W; Liu R; Yao C; Huo F; Shang Y; Zhang X; Wang Y; Xue Z; Ma L; Pang Y
Microbiol Spectr; 2022 Feb; 10(1):e0208721. PubMed ID: 35107324
[TBL] [Abstract][Full Text] [Related]
22. Molecular characterization of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Kazakhstan.
Kozhamkulov U; Akhmetova A; Rakhimova S; Belova E; Alenova A; Bismilda V; Chingissova L; Ismailov S; Ramanculov E; Momynaliev K
Jpn J Infect Dis; 2011; 64(3):253-5. PubMed ID: 21617314
[TBL] [Abstract][Full Text] [Related]
23. Rapid detection of mutations in rpoB gene of rifampicin resistant Mycobacterium tuberculosis strains by line probe assay.
Sharma M; Sethi S; Mishra B; Sengupta C; Sharma SK
Indian J Med Res; 2003 Feb; 117():76-80. PubMed ID: 12931842
[TBL] [Abstract][Full Text] [Related]
24. [Resistance to antituberculous drugs].
Veziris N; Cambau E; Sougakoff W; Robert J; Jarlier V
Arch Pediatr; 2005 Aug; 12 Suppl 2():S102-9. PubMed ID: 16129320
[TBL] [Abstract][Full Text] [Related]
25. Clinically relevant mutations in mycobacterial LepA cause rifampicin-specific phenotypic resistance.
Wang BW; Zhu JH; Javid B
Sci Rep; 2020 May; 10(1):8402. PubMed ID: 32439911
[TBL] [Abstract][Full Text] [Related]
26.
Swaminath S; Paul A; Pradhan A; Sebastian J; Nair RR; Ajitkumar P
Microbiology (Reading); 2020 Feb; 166(2):180-198. PubMed ID: 31746727
[TBL] [Abstract][Full Text] [Related]
27. High isoniazid resistance rates in rifampicin susceptible Mycobacterium tuberculosis pulmonary isolates from Pakistan.
Fasih N; Rafiq Y; Jabeen K; Hasan R
PLoS One; 2012; 7(11):e50551. PubMed ID: 23226311
[TBL] [Abstract][Full Text] [Related]
28. Cell Wall Proteomics Reveal Phenotypic Adaption of Drug-Resistant
Giddey AD; Ganief TA; Ganief N; Koch A; Warner DF; Soares NC; Blackburn JM
Front Med (Lausanne); 2021; 8():723667. PubMed ID: 34676224
[TBL] [Abstract][Full Text] [Related]
29. Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert® MTB/RIF in Kampala, Uganda: a retrospective study.
Mboowa G; Namaganda C; Ssengooba W
BMC Infect Dis; 2014 Sep; 14():481. PubMed ID: 25190040
[TBL] [Abstract][Full Text] [Related]
30. Profiling and identification of novel rpoB mutations in rifampicin-resistant Mycobacterium tuberculosis clinical isolates from Pakistan.
Qadir M; Tahseen S; McHugh TD; Hussain A; Masood F; Ahmed N; Faryal R
J Infect Chemother; 2021 Nov; 27(11):1578-1583. PubMed ID: 34244055
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis.
Larsen MH; Vilchèze C; Kremer L; Besra GS; Parsons L; Salfinger M; Heifets L; Hazbon MH; Alland D; Sacchettini JC; Jacobs WR
Mol Microbiol; 2002 Oct; 46(2):453-66. PubMed ID: 12406221
[TBL] [Abstract][Full Text] [Related]
32. Mycobacterium smegmatis RNA polymerase: DNA supercoiling, action of rifampicin and mechanism of rifampicin resistance.
Levin ME; Hatfull GF
Mol Microbiol; 1993 Apr; 8(2):277-85. PubMed ID: 8316080
[TBL] [Abstract][Full Text] [Related]
33. Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis.
Maus CE; Plikaytis BB; Shinnick TM
Antimicrob Agents Chemother; 2005 Feb; 49(2):571-7. PubMed ID: 15673735
[TBL] [Abstract][Full Text] [Related]
34. The Mycobacterial Efflux Pump EfpA Can Induce High Drug Tolerance to Many Antituberculosis Drugs, Including Moxifloxacin, in Mycobacterium smegmatis.
Rai D; Mehra S
Antimicrob Agents Chemother; 2021 Oct; 65(11):e0026221. PubMed ID: 34424047
[TBL] [Abstract][Full Text] [Related]
35. Characterization of mutations causing rifampicin and isoniazid resistance of Mycobacterium tuberculosis in Syria.
Madania A; Habous M; Zarzour H; Ghoury I; Hebbo B
Pol J Microbiol; 2012; 61(1):23-32. PubMed ID: 22708343
[TBL] [Abstract][Full Text] [Related]
36. [Mechanisms of action of and resistance to rifampicin and isoniazid in Mycobacterium tuberculosis: new information on old friends].
De La Iglesia AI; Morbidoni HR
Rev Argent Microbiol; 2006; 38(2):97-109. PubMed ID: 17037259
[TBL] [Abstract][Full Text] [Related]
37. Lsr2 and Its Novel Paralogue Mediate the Adjustment of Mycobacterium smegmatis to Unfavorable Environmental Conditions.
Kołodziej M; Łebkowski T; Płociński P; Hołówka J; Paściak M; Wojtaś B; Bury K; Konieczny I; Dziadek J; Zakrzewska-Czerwińska J
mSphere; 2021 May; 6(3):. PubMed ID: 33980681
[TBL] [Abstract][Full Text] [Related]
38. A rapid viability and drug-susceptibility assay utilizing mycobacteriophage as an indicator of drug susceptibilities of Anti-TB drugs against
Crowley GC; O'Mahony J; Coffey A; Sayers R; Cotter P
Int J Mycobacteriol; 2019; 8(2):124-131. PubMed ID: 31210153
[TBL] [Abstract][Full Text] [Related]
39. Ethidium bromide transport across Mycobacterium smegmatis cell-wall: correlation with antibiotic resistance.
Rodrigues L; Ramos J; Couto I; Amaral L; Viveiros M
BMC Microbiol; 2011 Feb; 11():35. PubMed ID: 21332993
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive phenotypic characterization of rifampicin resistance mutations in Salmonella provides insight into the evolution of resistance in Mycobacterium tuberculosis.
Brandis G; Pietsch F; Alemayehu R; Hughes D
J Antimicrob Chemother; 2015 Mar; 70(3):680-5. PubMed ID: 25362573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
